GlobeNewsWire
03 Nov 2025, 13:00 UTC · 46w ago
Verdict
Headline takes no side. We score OBIO +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 86% of ticker scores this week
Which stocks this story touches
More positive than 86% of ticker scores this week
The company announced significant clinical progress, financing developments, and strategic expansions with major partners.
More positive than 58% of ticker scores this week
Medtronic is expanding its strategic investment and collaboration with Orchestra BioMed.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 53% of ticker scores this week
Terumo has entered into a new right of first refusal agreement with Orchestra BioMed.
More positive than 53% of ticker scores this week
The company has entered into a new strategic capital relationship with Orchestra BioMed.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
5h ago
+52.1%
Price agrees with the score
$5.93 vs $3.90 close before publication (Oct 31) · not market-adjusted
OBIO chart →
